SCHEMBL16503738

SCHEMBL16503738

Cc1cc(Cl)cc(C(N)=O)c1NC(=O)c1cnc(Cn2nnc(C(F)(F)F)n2)nc1-c1ccccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EPAS1 Q99814 1/20 0.44
▸ PDE4B Q07343 3/20 0.38
▸ PDE4A P27815 1/20 0.38
▸ PDE4C Q08493 1/20 0.38
▸ PDE4D Q08499 1/20 0.38
▸ PDE3B Q13370 1/20 0.38
▸ PDE11A Q9HCR9 1/20 0.38
▸ NTRK1 P04629 7/20 0.36
▸ SLC2A1 P11166 4/20 0.35
▸ SLC2A3 P11169 4/20 0.35
▸ SLC2A4 P14672 4/20 0.35
▸ CHRNA7 P36544 1/20 0.34
▸ JUN P05412 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ NFKB2 Q00653 1/20 0.33
▸ RELA Q04206 1/20 0.33
▸ AVPR2 P30518 1/20 0.33
▸ AVPR1A P37288 1/20 0.33
▸ SLC2A2 P11168 1/20 0.33
▸ POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1696948 0.93 EPAS1 (0.42) EPAS1PDE4BPDE4APDE4CPDE4D
SCHEMBL16503752 0.92 SLC2A1 (0.41) EPAS1SLC2A1SLC2A3SLC2A4SLC2A2
SCHEMBL16503753 0.91 EPAS1 (0.41) EPAS1PDE4BPDE4APDE4CPDE4D
SCHEMBL16503748 0.91 EPAS1 (0.41) EPAS1PDE4BPDE4APDE4CPDE4D
SCHEMBL16503751 0.85 EPAS1 (0.38) EPAS1PDE4BPDE4APDE4CPDE4D
SCHEMBL16503732 0.84 F10 (0.35) EPAS1SLC2A1SLC2A3SLC2A4CHRNA7
SCHEMBL16503749 0.83 EPAS1 (0.37) EPAS1PDE4BPDE4APDE4CPDE4D
SCHEMBL16503763 0.83 EPAS1 (0.37) EPAS1PDE4BPDE4APDE4CPDE4D
SCHEMBL16503729 0.81 AVPR2 (0.35) EPAS1SLC2A1SLC2A3SLC2A4AVPR2
SCHEMBL1696960 0.80 EPAS1 (0.38) EPAS1AVPR2AVPR1APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8980886-B2 Anthranilic acid derivatives BAYER CROPSCIENCE AG (DE) 2015-03-17 — — US disclosed
US-8980886-B2 Anthranilic acid derivatives BAYER CROPSCIENCE AG (DE) 2015-03-17 — — US disclosed
US-20110312953-A1 ANTHRANILIC ACID DERIVATIVES BAYER CROPSCIENCE AG (DE) 2011-12-22 — — US disclosed
US-20110312953-A1 ANTHRANILIC ACID DERIVATIVES BAYER CROPSCIENCE AG (DE) 2011-12-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312953-A1 ANTHRANILIC ACID DERIVATIVES ANTXR2, NQO2, ACLY EPAS1 3339/4885PDE4B 768/4885PDE4A 756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback